Table 1.
Study | Sample size | Median | CI | Hazard ratio | Odds ratio for complications | AUC | |||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
Total | RC | FU | 90-d mortality | OCM | CSM | ||||
Malavaud 2001 [27] | 161 | 161 | NR | ASA | NR | NR | NR | 5.7 | NR |
Novotny 2012 [28] | 830 | 830 | NR | ASA | NR | NR | NR | NR | 0.609 |
Bostrom 2009 [29] | 258 | 258 | NR | ASA | NR | NR | NR | 3.25 [1.08–9.74] | NR |
Roghmann 2014 [30] | 535 | 535 | NR | CCI ASA |
NR | NR | NR | Overall complications: CCI 1.93 High grade complications: CCI 1.86; ASA 1.92 |
NR |
Fairey, 2008 [9] | 314 | 314 | NR | ACE-27 | ACE-27 severe: 6.4 | NR | NR | Overall complications: 5.2–7.0 High-grade complications: 11.4–15.2 |
NR |
ACE-27 = Adult Comorbidity Evaluation 27 score; ASA = American Society of Anesthesiology score; AUC = area under the receiver operating characteristic curve; CI = comorbidity index; CCI = Charlson CI; CSM = cancer-specific mortality; FU = follow-up; NR = not recorded; OCM = other-cause mortality; RC = radical cystectomy.